Generic Drug Analysis & Statistics, November 2012 (p5)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

121-150 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Global Biosimilars Market - Products, Applications and Regulations

Global Biosimilars Market - Products, Applications and Regulations

  • $ 4 320
  • Industry report
  • November 2012
  • by Industry Experts

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies’ ...

  • Industries : Biopharmaceutical, Biotechnology, Biological Therapy
  • Countries : Europe, World
Generic Drugs: World Market 2013-2023

Generic Drugs: World Market 2013-2023

  • $ 2 401
  • Industry report
  • November 2012
  • by Visiongain

Report Details Your guide to trends and sales potential for generics Where's the generic drugs market heading? Visiongain's updated report gives you revenue predictions to 2023. There you find data, trends, ...

  • Industries : Generic Drug
  • Countries : World, Europe
Biologics in the Emerging Markets - Ripe For Realization of the Commercial Potential - But Hurdles Still to Overcome

Biologics in the Emerging Markets - Ripe For Realization of the Commercial Potential - But Hurdles Still to Overcome

  • $ 3 900
  • Industry report
  • September 2012
  • by CBR Pharma Insights

Biologics cover a diverse range of products and deliverables and have revolutionized the treatment of many diseases. The complexity of biologics has made their manufacture an expensive and lengthy process ...

  • Industries : Generic Drug
  • Countries : BRIC
Profound Research and Investment Prospect of China’s Generic Drug Market, 2012-2016

Profound Research and Investment Prospect of China’s Generic Drug Market, 2012-2016

  • $ 1 800
  • Industry report
  • August 2012
  • by Huidian Research

By now, there are more than 10,000 kinds of generic drugs in China, accounting for the vast majority of drug consumption market. There are more and more drug varieties and the quality becomes better and ...

  • Industries : Generic Drug
  • Countries : China
Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

  • $ 3 500
  • Industry report
  • July 2012
  • by GBI Research

Summary GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways ...

  • Industries : Generic Drug
  • Countries : Europe
Global Biosimilars Market Report: 2012 Edition

Global Biosimilars Market Report: 2012 Edition

  • $ 800
  • Industry report
  • July 2012
  • by Koncept Analytics

The biosimilar market is presently a small segment of the pharmaceutical industry. However, in the years to come, the market for biosimilars has huge growth opportunity despite of the high entry barriers. ...

  • Industries : Biopharmaceutical
  • Countries : World
Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth Summary GBI Research in its present report ”Generics ...

  • Industries : Pharmaceutical, Generic Drug, Pathology, Drug and Medication, Therapy
  • Countries : World
Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production Summary GBI Research, the ...

  • Industries : Generic Drug
  • Countries : China, India
The “Patent Cliff”: How Pfizer has responded to the loss of its best-selling drug

The “Patent Cliff”: How Pfizer has responded to the loss of its best-selling drug

  • $ 495
  • Company report
  • June 2012
  • by MarketLine

Introduction The pharmaceuticals market was worth $733bn in 2010. The top four market players (Pfizer Limited, Merck & Co., AstraZeneca, and GlaxoSmithKline) had a market share of 22.3%. Pfizer has been ...

  • Industries : Generic Drug, Pharmaceutical, Drug and Medication
  • Countries : China, Asia
The

The "Patent Cliff": How Pfizer has responded to the loss of its best-selling drug

  • $ 495
  • Company report
  • June 2012
  • by MarketLine

Introduction The pharmaceuticals market was worth $733bn in 2010. The top four market players (Pfizer Limited, Merck & Co., AstraZeneca, and GlaxoSmithKline) had a market share of 22.3%. Pfizer has been ...

  • Industries : Generic Drug, Drug and Medication, Pharmaceutical
  • Countries : China, Asia
Cancer Generics Market Analysis

Cancer Generics Market Analysis

  • $ 1 000
  • Industry report
  • June 2012
  • by RNCOS

Across the globe, oncology market, one of the fastest growing segments of pharmaceutical industry, has been expanding on back of rising cancer incidences, and hefty investment by private players. According ...

  • Industries : Pharmaceutical, Pathology, Drug and Medication
  • Countries : World
Asia Pacific Pharma Sector Analysis

Asia Pacific Pharma Sector Analysis

  • $ 1 300
  • Industry report
  • June 2012
  • by RNCOS

The Asia-Pacific region is emerging as the fastest growing pharmaceutical industry in the global pharmaceutical arena. In the recent years, the demand for healthcare services has risen among the region’s ...

  • Industries : Pharmaceutical, Drug and Medication
  • Countries : Asia
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

  • $ 3 500
  • Industry report
  • May 2012
  • by GBI Research

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution Summary GBI Research, the leading business ...

  • Industries : Pathology, Generic Drug, Pharmaceutical
  • Countries : World
EPO Biosimilars Market Forecast to 2015

EPO Biosimilars Market Forecast to 2015

  • $ 300
  • Industry report
  • May 2012
  • by RNCOS

The biosimilars industry has been growing stupendously across the globe for the past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid ...

  • Industries : Generic Drug, Biopharmaceutical
  • Countries : World
G-CSF Biosimilars Market Forecast to 2015

G-CSF Biosimilars Market Forecast to 2015

  • $ 300
  • Industry report
  • May 2012
  • by RNCOS

For the past few years, the biosimilars industry has been growing stupendously across the globe due to increasing healthcare costs and rising aging population. It is expected to evolve, to a great extent, ...

  • Industries : Biological Therapy, Generic Drug
  • Countries : World
HGH Biosimilars Market Forecast to 2015

HGH Biosimilars Market Forecast to 2015

  • $ 300
  • Industry report
  • May 2012
  • by RNCOS

Across the globe, the biosimilars industry has been growing stupendously for the past few years. Increasing healthcare costs and rising aging population are driving the industry that is expected to evolve ...

  • Industries : Generic Drug, Biopharmaceutical
  • Countries : World
Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure

Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure

  • $ 3 500
  • Industry report
  • April 2012
  • by GBI Research

Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure Summary GBI Research, the leading business intelligence ...

  • Industries : Generic Drug
  • Countries : Europe
Branded Generics in South East Asia: Current and Future Opportunities

Branded Generics in South East Asia: Current and Future Opportunities

  • $ 1 495
  • Industry report
  • April 2012
  • by Firstword Pharma

With its fast-growing, young population and projected pharmaceutical sales in excess of $20 billion in 2014, countries in the Association of South East Asian Nations (ASEAN) represent a great opportunity ...

  • Industries : Generic Drug
  • Countries : Asia
Generics as a Vehicle to Improve Market Access

Generics as a Vehicle to Improve Market Access

  • $ 695
  • Industry report
  • April 2012
  • by Firstword Pharma

In low and middle-income countries, around 17.6 million people each year die of treatable infectious diseases, reproductive health issues, and childhood illnesses. Millions more experience poor quality ...

  • Industries : Generic Drug
Assessment of the Japan Generics Industry

Assessment of the Japan Generics Industry

  • $ 800
  • Industry report
  • March 2012
  • by Smart Research Insights

Executive Summary While Japan is the second largest pharma market globally, it has a very low penetration rate of generic drugs. The country’s government has set an ambitious goal to enhance the generics ...

  • Industries : Generic Drug
  • Countries : Japan
Japan Generics Market Analysis

Japan Generics Market Analysis

  • $ 1 000
  • Industry report
  • February 2012
  • by RNCOS

Japan is the world’s second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained low in it. However, worried over rising healthcare expenses ...

  • Industries : Generic Drug
  • Countries : Japan
World GenericMarkets

World GenericMarkets

  • $ 1 038
  • Industry report
  • January 2012
  • by Espicom Business Intelligence

World Generic Markets is the business publication designed to keep executives and industry analysts in touch with the latest developments in the world of generic pharmaceuticals. In recent years, the numbe ...

  • Industries : Generic Drug
  • Countries : World
Generic Drugs BusinessChannel

Generic Drugs BusinessChannel

  • $ 3 578
  • Industry report
  • January 2012
  • by Espicom Business Intelligence

On the back of the industry’s increasingly strong market position - driven by favourable political environments and the number of medicines losing patent protection - industry and investors are re-evaluating ...

  • Industries : Generic Drug
  • Countries : World
Gauging the Biosimilar Effect: will  the market boom or bust?

Gauging the Biosimilar Effect: will the market boom or bust?

  • $ 895
  • Industry report
  • January 2012
  • by Firstword Pharma

It was supposed to be the “epoch of biosimilars”, or drugs that copied existing biologics but had the potential to be more cost-effective. Yet five years later, biosimilars have failed to reach ...

  • Industries : Generic Drug
  • Countries : Germany
Generic Pharmaceuticals Market - A Global Analysis

Generic Pharmaceuticals Market - A Global Analysis

  • $ 6 500
  • Industry report
  • December 2011
  • by Frost & Sullivan

The research service aims to analyse and assess the global generics pharmaceutical market, map the key trends and dynamics shaping the industry sector and provide strategic recommendations for the success ...

  • Industries : Generic Drug
  • Countries : Europe, World
Analysis of European Biosimilars Market

Analysis of European Biosimilars Market

  • $ 6 500
  • Industry report
  • December 2011
  • by Frost & Sullivan

The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success ...

  • Industries : Generic Drug
  • Countries : Europe
Specialty Physicians Discuss their Opinions of the United States Biosimilars Market

Specialty Physicians Discuss their Opinions of the United States Biosimilars Market

  • $ 10 000
  • Industry report
  • December 2011
  • by Frost & Sullivan

The U.S. biosimilars market is a fast approaching reality. However, much uncertainty lies ahead, including the market potential as a function of physician adoption of biosimilars. This panel discussion ...

  • Industries : Generic Drug
  • Countries : United States
Biosimilar Drugs in Europe: threat or opportunity to innovation?

Biosimilar Drugs in Europe: threat or opportunity to innovation?

  • $ 595
  • Industry report
  • November 2011
  • by Firstword Pharma

Between now and 2019, a vast range of blockbuster drugs will go off patent, opening the floodgates in the EU to the biosimilars market. Already established there since 2006, biosimilars are set to be ...

  • Industries : Generic Drug
  • Countries : Europe
Generic Drug Market in Canada

Generic Drug Market in Canada

  • $ 1 000
  • Industry report
  • November 2011
  • by RNCOS

Canada is one of the world’s largest pharmaceutical markets, even though it has a low share of only 3% in global pharma industry. In 2010, generics accounted for more than 57% prescriptions and around ...

  • Industries : Generic Drug, Pharmaceutical, Drug and Medication
  • Countries : Canada
Multi-therapy Drugs: Opportunities for Generics & Biosimilars

Multi-therapy Drugs: Opportunities for Generics & Biosimilars

  • $ 1 679
  • Industry report
  • October 2011
  • by Espicom Business Intelligence

Targeting multiple conditions is likely to increase a drug’s potential target audience and result in large financial returns for the developing company. With annual sales counted in billions of dollars, ...

  • Industries : Generic Drug

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.